These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 11072781)

  • 1. Role of MAP kinase in the enhanced cell proliferation of long term estrogen deprived human breast cancer cells.
    Jeng MH; Yue W; Eischeid A; Wang JP; Santen RJ
    Breast Cancer Res Treat; 2000 Aug; 62(3):167-75. PubMed ID: 11072781
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enhanced estrogen receptor (ER) alpha, ERBB2, and MAPK signal transduction pathways operate during the adaptation of MCF-7 cells to long term estrogen deprivation.
    Martin LA; Farmer I; Johnston SR; Ali S; Marshall C; Dowsett M
    J Biol Chem; 2003 Aug; 278(33):30458-68. PubMed ID: 12775708
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Estrogen receptor expression and function in long-term estrogen-deprived human breast cancer cells.
    Jeng MH; Shupnik MA; Bender TP; Westin EH; Bandyopadhyay D; Kumar R; Masamura S; Santen RJ
    Endocrinology; 1998 Oct; 139(10):4164-74. PubMed ID: 9751496
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adaptive hypersensitivity to estradiol: potential mechanism for secondary hormonal responses in breast cancer patients.
    Santen R; Jeng MH; Wang JP; Song R; Masamura S; McPherson R; Santner S; Yue W; Shim WS
    J Steroid Biochem Mol Biol; 2001 Dec; 79(1-5):115-25. PubMed ID: 11850215
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular changes associated with the acquisition of oestrogen hypersensitivity in MCF-7 breast cancer cells on long-term oestrogen deprivation.
    Chan CM; Martin LA; Johnston SR; Ali S; Dowsett M
    J Steroid Biochem Mol Biol; 2002 Aug; 81(4-5):333-41. PubMed ID: 12361723
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Kinome-wide functional screen identifies role of PLK1 in hormone-independent, ER-positive breast cancer.
    Bhola NE; Jansen VM; Bafna S; Giltnane JM; Balko JM; Estrada MV; Meszoely I; Mayer I; Abramson V; Ye F; Sanders M; Dugger TC; Allen EV; Arteaga CL
    Cancer Res; 2015 Jan; 75(2):405-14. PubMed ID: 25480943
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Activation of the MAPK pathway enhances sensitivity of MCF-7 breast cancer cells to the mitogenic effect of estradiol.
    Yue W; Wang JP; Conaway M; Masamura S; Li Y; Santen RJ
    Endocrinology; 2002 Sep; 143(9):3221-9. PubMed ID: 12193533
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Elevated ERK1/ERK2/estrogen receptor cross-talk enhances estrogen-mediated signaling during long-term estrogen deprivation.
    Martin LA; Farmer I; Johnston SR; Ali S; Dowsett M
    Endocr Relat Cancer; 2005 Jul; 12 Suppl 1():S75-84. PubMed ID: 16113101
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of human estrogen receptor using an efficient adenoviral gene delivery system is able to restore hormone-dependent features to estrogen receptor-negative breast carcinoma cells.
    Lazennec G; Katzenellenbogen BS
    Mol Cell Endocrinol; 1999 Mar; 149(1-2):93-105. PubMed ID: 10375022
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel antitumor effect of estradiol in athymic mice injected with a T47D breast cancer cell line overexpressing protein kinase Calpha.
    Chisamore MJ; Ahmed Y; Bentrem DJ; Jordan VC; Tonetti DA
    Clin Cancer Res; 2001 Oct; 7(10):3156-65. PubMed ID: 11595710
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Estrogen and pure antiestrogen fulvestrant (ICI 182 780) augment cell-matrigel adhesion of MCF-7 breast cancer cells through a novel G protein coupled estrogen receptor (GPR30)-to-calpain signaling axis.
    Chen Y; Li Z; He Y; Shang D; Pan J; Wang H; Chen H; Zhu Z; Wan L; Wang X
    Toxicol Appl Pharmacol; 2014 Mar; 275(2):176-81. PubMed ID: 24440569
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metalloestrogenic effects of cadmium are absent in long-term estrogen-deprived MCF-7 cells: Evidence for the involvement of constitutively activated estrogen receptor α and very low expression of G protein-coupled estrogen receptor 1.
    Hirao-Suzuki M; Takeda S; Kodama Y; Takiguchi M; Toda A; Ohara M
    Toxicol Lett; 2020 Feb; 319():22-30. PubMed ID: 31689473
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Estrogen-induced activation of the mitogen-activated protein kinase cascade in the cerebral cortex of estrogen receptor-alpha knock-out mice.
    Singh M; Sétáló G; Guan X; Frail DE; Toran-Allerand CD
    J Neurosci; 2000 Mar; 20(5):1694-700. PubMed ID: 10684871
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of prolonged hydroxytamoxifen treatment of MCF-7 cells on mitogen activated kinase cascade.
    Rabenoelina F; Semlali A; Duchesne MJ; Freiss G; Pons M; Badia E
    Int J Cancer; 2002 Apr; 98(5):698-706. PubMed ID: 11920638
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prolonged extracellular signal-regulated kinase 1/2 activation during fibroblast growth factor 1- or heregulin beta1-induced antiestrogen-resistant growth of breast cancer cells is resistant to mitogen-activated protein/extracellular regulated kinase kinase inhibitors.
    Thottassery JV; Sun Y; Westbrook L; Rentz SS; Manuvakhova M; Qu Z; Samuel S; Upshaw R; Cunningham A; Kern FG
    Cancer Res; 2004 Jul; 64(13):4637-47. PubMed ID: 15231676
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The anti-oestrogen ICI 182,780, but not tamoxifen, inhibits the growth of MCF-7 breast cancer cells refractory to long-term oestrogen deprivation through down-regulation of oestrogen receptor and IGF signalling.
    Martin LA; Pancholi S; Chan CM; Farmer I; Kimberley C; Dowsett M; Johnston SR
    Endocr Relat Cancer; 2005 Dec; 12(4):1017-36. PubMed ID: 16322340
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Models of estrogen receptor regulation by estrogens and antiestrogens in breast cancer cell lines.
    Pink JJ; Jordan VC
    Cancer Res; 1996 May; 56(10):2321-30. PubMed ID: 8625307
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Estradiol hypersensitivity and mitogen-activated protein kinase expression in long-term estrogen deprived human breast cancer cells in vivo.
    Shim WS; Conaway M; Masamura S; Yue W; Wang JP; Kmar R; Santen RJ
    Endocrinology; 2000 Jan; 141(1):396-405. PubMed ID: 10614662
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of long-term estrogen deprivation on apoptotic responses of breast cancer cells to 17beta-estradiol.
    Song RX; Mor G; Naftolin F; McPherson RA; Song J; Zhang Z; Yue W; Wang J; Santen RJ
    J Natl Cancer Inst; 2001 Nov; 93(22):1714-23. PubMed ID: 11717332
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Src Is a Potential Therapeutic Target in Endocrine-Resistant Breast Cancer Exhibiting Low Estrogen Receptor-Mediated Transactivation.
    Guest SK; Ribas R; Pancholi S; Nikitorowicz-Buniak J; Simigdala N; Dowsett M; Johnston SR; Martin LA
    PLoS One; 2016; 11(6):e0157397. PubMed ID: 27308830
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.